On Monday, Silence Therapeutics plc (NASDAQ:SLN) presented end-of-treatment data from its Phase 2 ALPACAR-360 study of ...

A recent study published in the Journal of Translational Internal Medicine reveals insights into the broader impact of ...

The trials include: KRAKEN, a randomised phase 2 trial of Muvalaplin, the first oral drug that targets Lipoprotein(a) particles BROOKLYN, which is investigating the safety and efficacy of Obicetrapib ...

Parsley has many medicinal applications, including as a potential aid for muscle cramps and dermatitis. Find a list of ...